On December 27, 2023, Ruibo (Hangzhou) Pharmaceutical Technology Co., Ltd. closed the transaction. The company has completed the industrial and commercial change registration and obtained a new Business License issued by the Hangzhou Qiantang District Market Supervision Administration.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15.81 CNY | -2.47% | -4.12% | -34.70% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.70% | 2.02B | |
+31.37% | 588B | |
-2.69% | 364B | |
+20.66% | 326B | |
+5.73% | 285B | |
+14.83% | 239B | |
+9.93% | 210B | |
-6.95% | 200B | |
+11.13% | 167B | |
0.00% | 161B |
- Stock Market
- Equities
- 603456 Stock
- News Zhejiang Jiuzhou Pharmaceutical Co., Ltd
- Ruibo Pharmaceutical Technology Co., Ltd. announced that it has received CNY 50 million in funding from Zhejiang Jiuzhou Pharmaceutical Co., Ltd